宇華教育(06169.HK)完成發行20.88億港元可換股債
格隆匯12月27日丨宇華教育(06169.HK)公告,有關建議根據一般授權發行20.88億港元於2024年到期的可換股債券以及建議購回現有可換股債券。公司欣然宣佈今日已完成發行可換股債券。
可換股債券的總髮行量為20.88億港元,自2020年6月27日起(包括該日)的未償還本金額按年息率0.90%計息,應每半年於每年6月27日及12月27日支付,直至到期日為止。該等條件規定,各可換股債券持有人可於轉換期隨時轉換可換股債券為入賬列作繳足的轉換股份。
公司亦欣然宣佈其已完成購回,而購回總額為9.28億港元的現有可換股債券已被註銷。於購回完成後,並無餘下尚未償還的現有可換股債券。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.